We are pleased to announce that the 16th edition of the International Workshop on Clinical Pharmacology of Tuberculosis Drugs will take place October 14-15, 2026, as a virtual meeting.
This abstract-driven workshop has been a leading annual meeting in the field of tuberculosis (TB) pharmacology since 2008. The aim of the meeting is to contribute to the optimization of TB treatment by providing an independent platform for the presentation and discussion of the latest scientific developments in TB pharmacology.
If you work in TB, you are invited to join us. This includes preclinical and clinical pharmacology researchers from academia and industry; medical doctors, pharmacists, and pharmacologists involved in clinical management of TB patients; laboratorians, nurses, and PhD students; and representatives from regulatory or non-governmental organizations active in the TB field.
The program consists of oral presentations that will be put in perspective, with a translation to clinical care where possible, by selected experts at the end of each workshop session. In addition, there will be e-poster abstract presentations. The workshop is informal in setting and is meant to be interactive.
We look forward to seeing you virtually this October!